News & Updates
Filter by Specialty:
Erenumab effective for migraine regardless of aura status
In a post hoc analysis, use of the anti-CGRP* receptor monoclonal antibody erenumab led to reduced migraine frequency and AMSM** days in individuals with migraine with and without a history of aura.
Erenumab effective for migraine regardless of aura status
28 Jan 2022
Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life
Among patients with epilepsy, quality of life (QOL) declines with antiseizure medication (ASM) polytherapy, and this effect is mediated by depression and the side effects of ASMs, as reported in a study.
Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life
17 Jan 2022
Young-onset dementia common in Southeast Asia
Young-onset dementia (YOD), particularly the Alzheimer’s type, occurs with high frequency among Southeast Asians, according to data from a memory clinic cohort in Singapore. Furthermore, YOD patients with higher education and those who have late-onset dementia with moderate-to-severe cerebrovascular disease burden exhibit a steeper and faster decline in global cognition.
Young-onset dementia common in Southeast Asia
14 Jan 2022
Psychosis not uncommon in Parkinson’s disease, signals cognitive decline
A significant presence of psychosis exists among patients with Parkinson’s disease (PD) in Singapore, potentially indicating a more rapid cognitive decline and progression of PD severity, reports a study.
